You might like
Congrats to Julie Hinchman and Kelly Terrell, the first recipients of the Peter Westervelt, MD, PhD, Nursing Education Fund Scholarship Award! This honor recognizes outstanding oncology nurses at Siteman by providing resources and support for continued education.
RIDE MUSTANGS RIDE!!! 💙💚
Check out our Blue/Green Team competition routine! 4th in the JV Large Division! 💙💚
Siteman Deputy Director Dr. John DiPersio, MD, PhD, discusses the @WUSTLmed research being presented at #ASH21.
Join us live on Facebook this Tuesday, December 7, at 10 a.m, for a Cellular & CAR T-cell Therapies Q&A with @WUSTLmed experts Armin Ghobadi, MD, and Amanda Cashen, MD. Learn about these therapies and ask our experts questions throughout the event: ow.ly/XfK350H1pvv
Now on Nucleus: "Bispecific T-cell engagers (BiTEs) and antibody-drug conjugates (ADCs) 'appear to have tolerable safety and reasonable efficacy profiles' in the treatment of relapsed or refractory multiple myeloma" nucleus.astct.org/Patient-Care/b…
The @acs_missouri #HopeLodgeSTL has been an incredible resource for so many Siteman patients. We're honored to host not one but two of the #42Doors of Hope on the grounds of Siteman's main campus (Door 22) and north county (Door 32) locations. Learn more: 42doorsofhope.org
Transitional Care Management, including the use of an upgraded EMR, has lowered 30-, 14- and 7-day readmission rates for BMT patients. See @TerrellK711's poster on retrospective outcome data: 6:15-7:45 pm, Palms & Cypress Foyers. ow.ly/Ugvb50ysCnM #TCTM20
Ramzi Abboud, MD, (@ramziabb) will discuss data that’s the first to show that mild (grade 1-2) CRS is associated with a lower rate of relapse without affecting TRM, thereby improving OS, today at #TCTM20: 5 pm, Palms: Royal. Abstract: ow.ly/Y5ab50ysyJr
CD34+ cell mobilization w/plerixafor + MGTA-145 is immediate and superior to plerixafor alone, according to a phase 1 clinical study led by our deputy director, John DiPersio, MD, PhD. He presents findings today at #TCTM20: 4:45 pm, Palms: Royal. Abstract: ow.ly/oAsT50ytgLB
Love seeing our leaders at this national conference!
Allogeneic HCT remains a potential curative treatment option for high-risk HCT patients, according to Kelly Terrell, RN (@TerrellK711). She presents on the topic today at #TCTM20: 3:30-3:45 pm in Crystal: G. Abstract: ow.ly/XKyd50ysKDF
Want to optimize your EMR system for CAR T-cell therapy? Andrea Price, NP, (@andiprice82) and Dylan Essner discuss the opportunities and pitfalls, at #TCTM20: 2:10 pm today in Palms: Canary 1-2. More info: ow.ly/TwRf50yqRjI
Looking forward to highlighting our Cellular Therapy Program tomorrow! We have lots of brilliant team members presenting at the conference #TCTM20 !
Attending #TCTM20? Here's the list of presentations by our @WUSTLmed researchers and caregivers: siteman.wustl.edu/astct
.@WUSTLmed has received a $5M grant from the Edward P. Evans Foundation to establish a new center focused on researching & improving treatments for myelodysplastic syndromes, or #MDS, a rare set of blood disorders. The new center will be led by Siteman's Matthew Walter, MD.
@julietelken @JoeySims66 @Betz5thgraders ray ban outlet online $24.99 Buy CLICK:@http://www.rbstoreshop.com
@drmonicav @991JOYFM @brtirat_43 Ray Ban For Sale Cheap for sale $24.99 Buy CLICK:@http://www.rbstoreshop.com
We had a great time with @LisaGHart ! Thanks for coming this morning! #thisisballwin
United States Trends
- 1. Broncos N/A
- 2. Broncos N/A
- 3. Mecole Hardman N/A
- 4. Jordan Humphrey N/A
- 5. Surtain N/A
- 6. Tony Romo N/A
- 7. Bo Nix N/A
- 8. #BUFvsDEN N/A
- 9. Jake Lang N/A
- 10. James Cook N/A
- 11. Pat Bryant N/A
- 12. Sean Payton N/A
- 13. Seahawks N/A
- 14. Virginia N/A
- 15. Dorian Williams N/A
- 16. Gators N/A
- 17. Mims N/A
- 18. #iubb N/A
- 19. Hubert N/A
- 20. Xaivian Lee N/A
Something went wrong.
Something went wrong.